Need help navigating aged care? Explore our support services
Aged Care Home
Support at Home
Retirement Living
Finance & Placement Advice
Healthcare Equipment
Mobility and Equipment
Patient care equipment
Skin and wound Care
Safety and Security
Assessments
Assistive Technology
End of Life
Financial Services
Funerals
Placement Consultants
Advocacy
No results found
No results found
No results found
Advanced Filters
Distance (proximity)
Price Range
RAD (Refundable Accommodation Deposit) is a lump-sum payment for aged care homes. It is fully refundable when the resident leaves, as long as there are no outstanding fees.
Min RAD
Any
$250,000
$500,000
$750,000
$1,000,000
$1,500,000
$1,750,000
$2,000,000
Maximum RAD
Any
$250,000
$500,000
$750,000
$1,000,000
$1,500,000
$1,750,000
$2,000,000
Facility size
Based on how many beds the facilty has.
Any
Small
Medium
Large
Service Delivery
Services offered at a location or in a region
Any
On Site
Service Region
Features
Single rooms with ensuites
Respite beds
Extra service beds
Secure dementia beds
24/7 Registered nursing
Full or Partially government funded
Couples accommodation
Facility has pets
Non-dedicated respite
Palliative care
Partner considered without ACAT
Secure garden
Transition care
Cafe/Kiosk
Chapel/Church
Hairdressing Salon
Facility Owned Transport
Single Rooms
Rooms with ensuites
Registered nursing
Non secure dementia care
Diversional therapy
Medication supervision
Respite care
Secure access
Small pets considered

Who is behind the medicines information on the internet?

Posted
by DPS

Pharmaceutical companies are tapping into online social networking sites such as Facebook and MySpace and using new media forms to reach wider Australian audiences. Writing in the latest edition of Australian Prescriber, health journalist Melissa Sweet discusses how the internet is helping to globalise and change pharmaceutical marketing, and how this poses challenges for regulators.
 
The article gives examples of evolving marketing practices such as using overseas blogs and websites in countries where pharmaceutical marketing is less regulated than in Australia to promote and sell products. Ms Sweet claims companies are using blogs and websites to develop customer relationships which may enable companies to gather patient stories and feedback for use in positioning their products, although consumers are often not aware of their involvement.
 
The article discusses how pharmaceutical companies are seeking to capitalise on medical social networking sites. One site earns money by letting clients such as hedge funds monitor doctors’ anonymous online conversations and thus gain insight into, say, the popularity of certain treatments.
 
She acknowledges Medicines Australia’s efforts to police the promotion of medicines, but concludes that such regulation is going to become increasingly harder as technology evolves.

 

Read next

Sign up or log in with your phone number
Phone
Enter your phone number to receive a verification notification
Aged Care Guide is endorsed by
COTA logo
ACIA logo